Pfizer sues Sun Pharma for patent infringement

13-09-2016

Pfizer sues Sun Pharma for patent infringement

pio3 / shutterstock.com

Pfizer has sued Indian generic company Sun Pharma for allegedly infringing patents centring on Xeljanz (tofacitinib), a treatment for rheumatoid arthritis.


Pfizer, Sun Pharma, patent infringement, Xeljanz, Delhi High Court

More on this story

Sun Pharma takes Pfizer to court over Lyrica
08-04-2019

LSIPR